Bio-Connect

ELISA Kit for Serum Amyloid A (SAA)

CEA885HU
Cloud-Clone Corp.
Product group Assays
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Cloud-Clone Corp.
  • Product Name
    ELISA Kit for Serum Amyloid A (SAA)
  • Delivery Days Customer
    12
  • Assay Detection Range
    39.06-10,000ng/mL
  • Assay Precision
    Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Serum Amyloid A (SAA) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with low, middle and high ...
  • Assay Sensitivity
    The minimum detectable dose of this kit is typically less than 14.73ng/mL
  • Assay Test Principle
    This assay employs the competitive inhibition enzyme immunoassay technique. A monoclonal antibody specific to Serum Amyloid A (SAA) has been pre-coated onto a microplate. A competitive inhibition reaction is launched between biotin labeled Serum ...
  • Assay Time
    2h
  • Certification
    Research Use Only
  • UNSPSC
    41116158

References

  • Timur H, Yimaz N, Kahyaoglu I, et al. The effect of serum and follicular fluid amyloid-associated protein levels on in vitro fertilization outcome in patients with polycystic ovary syndrome. J Assist Reprod Genet. 2015,32(11):1637-42. doi: 10.1007/s10815-015-0582-3
    Read this paper
  • Moura Neto A, Parisi MC, Alegre SM, et al. Relation of thyroid hormone abnormalities with subclinical inflammatory activity in patients with type 1 and type 2 diabetes mellitus. Endocrine. 2016,51(1):63-71. doi: 10.1007/s12020-015-0651-5
    Read this paper
  • Upur H, Chen Y, Kamilijiang M, et al. Identification of plasma protein markers common to patients with malignant tumour and Abnormal Savda in Uighur medicine: a prospective clinical study. BMC Complement Altern Med. 2015,15:9. doi: 10.1186/s12906-015-0526-6
    Read this paper
  • Eren E, Ellidag HY, Yılmaz A, et al. No association between vitamin D levels and inflammation markers in patients with acute coronary syndrome. Adv Med Sci. 2015,60(1):89-93. doi: 10.1016/j.advms.2014.12.003
    Read this paper
  • Nasiripour S, Gholami K, Mousavi S, et al. Comparison of the Effects of Enoxaparin and Heparin on Inflammatory Biomarkers in Patients with ST-segment Elevated Myocardial Infarction: A prospective Open Label Pilot Clinical Trial. Iran J Pharm Res. 2014,13(2):583-90.
    Read this paper
  • Eren E, Ellidag HY, Yılmaz A, et al. Acute Phase Response: Implication in ST-segment Elevation Myocardial Infarction. Open Biochem J. 2014,8:44-51. doi: 10.2174/1874091X01408010044
    Read this paper